British Journal of Pharmacology · 2007 · 42 citations · 20 references
MedicineCardiologyPharmacologyMetabolic RegulationMolecular PharmacologySignal TransductionBlood Pressure ControlBlood Pressure RegulationCardiovascular PharmacodynamicsCardiovascular PharmacologyCardiovascular PhysiologyHemodynamic PharmacologyArterial Blood Pressure ControlBlood PressureLipid Metabolism EffectsLiver X Receptor SignalingPlasma Renin ActivityRenin-angiotensin System ModulationRenin-angiotensin-aldosterone SignalingRenin-angiotensin-aldosterone System Activation
BACKGROUND AND PURPOSE: Liver X receptors (LXRs) activate genes that regulate lipid and cholesterol metabolism. LXR agonists were shown recently to also increase murine renin gene expression in vivo. To further examine a link between lipid metabolism, the renin-angiotensin-aldosterone-system and blood pressure regulation, we investigated the effect of a LXR agonist (GW3965) on angiotensin II (Ang II)-mediated vasoreactivity and vascular angiotensin II receptor (ATR) gene expression. EXPERIMENTAL APPROACH: Arterial blood pressure (BP) was measured during Ang II infusions (1.5 min duration; 0.001-3 microg kg(-1)) in pentobarbital-anesthetized male Sprague-Dawley rats (n = 6-9) after oral administration of GW3965 (10 mg kg(-1), q.d.) or vehicle for 7 - 15 days. Mesenteric arteries and plasma were collected to analyze ATR gene expression and to measure plasma renin activity (PRA) and lipid profile, respectively. KEY RESULTS: Basal mean arterial pressure (MAP) was similar between groups. GW3965 dosing blunted the vasopressor effect of Ang II, which was significantly different with the 0.3 and 3 microg kg(-1) doses. No difference in heart rate, PRA or lipid profile was observed between groups. A time-course indicated that ATR type 1 and 2 gene expression of GW3965-treated vs. vehicle-treated rats decreased by 50%, reaching significance for ATR type 2, but not for ATR type 1, at time-points coinciding with BP measurements. CONCLUSIONS AND IMPLICATIONS: GW3965 decreased Ang II-mediated vasopressor responses coincident with a trend toward reduced ATR gene expression, suggesting that LXR agonists could affect vascular reactivity.
20
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Bethany A. Janowski, Patricia J. Willy, Thota Rama Devi et al. · Nature · 1996 · 1.7K citations
Role of LXRs in control of lipogenesis
Joshua R. Schultz, Hua Tu, Alvin Luk et al. · Genes & Development · 2000 · 1.7K citations · Full text
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Sean B. Joseph, Antonio Castrillo, Bryan Laffitte et al. · Nature Medicine · 2003 · 1.1K citations